NewAmsterdam Pharma Company N.V. (NAMS) Free Cash Flow by Year
NewAmsterdam Pharma Company N.V. recorded an outflow of $148.0M in free cash flow in fiscal year 2025. This represents an increase of 7.0% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to an outflow of $143.7M in free cash flow. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters NewAmsterdam Pharma Company N.V. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
NAMS Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
NAMS Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More NewAmsterdam Pharma Company N.V. financials
Frequently Asked Questions
What was NewAmsterdam Pharma Company N.V.'s free cash flow in fiscal year 2025?
NewAmsterdam Pharma Company N.V. recorded an outflow of $148.0M in free cash flow in fiscal year 2025.
How fast is NewAmsterdam Pharma Company N.V.'s free cash flow growing?
NewAmsterdam Pharma Company N.V. (NAMS) free cash flow rose by 7.0% year over year, from -$159.2M to -$148.0M in fiscal year 2025.
What is NewAmsterdam Pharma Company N.V.'s free cash flow over the last twelve months?
NewAmsterdam Pharma Company N.V. (NAMS) reported an outflow of $143.7M in free cash flow over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has NewAmsterdam Pharma Company N.V.'s free cash flow changed over the years?
Across the 5 fiscal years this page covers, NewAmsterdam Pharma Company N.V. (NAMS) free cash flow went from -$29.5M in fiscal year 2021 to -$148.0M in fiscal year 2025.
What was NewAmsterdam Pharma Company N.V.'s free cash flow in the most recent quarter?
NewAmsterdam Pharma Company N.V. (NAMS) reported -$39.3M in free cash flow in Q2 2026. This represents a decrease of 4.1% from the same quarter a year earlier.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what NewAmsterdam Pharma Company N.V. (NAMS) reported on that line in every period on record.